BDBM156373 US9018371, 14

SMILES OC1CS[C@H]([C@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12

InChI Key InChIKey=IDVXTFYPPUNLDO-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 156373   

TargetAdenosine receptor A2a(Human)
Fm Therapeutics

US Patent
LigandPNGBDBM156373(US9018371, 14)
Affinity DataKi:  2.5nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Fm Therapeutics

US Patent
LigandPNGBDBM156373(US9018371, 14)
Affinity DataKi:  230nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Fm Therapeutics

US Patent
LigandPNGBDBM156373(US9018371, 14)
Affinity DataKi:  530nMAssay Description:CHO cells (ATCC No. CCL-61), in which A1 and A3 adenosine receptors were expressed, were cultured in F-12 media (Gibco, U.S.A.) supplemented with 10%...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2015
Entry Details
US Patent